Alirocumab — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12-29 in 3mo
ESTIMATED |
READOUT
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult P
Phase 2 · Hypercholesterolemia |
REGN REGENERON PHARMACEUTICALS, I | Alirocumab |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
|